| __timestamp | Taro Pharmaceutical Industries Ltd. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 179279000 | 22622695 |
| Thursday, January 1, 2015 | 186359000 | 24863028 |
| Friday, January 1, 2016 | 171785000 | 21351001 |
| Sunday, January 1, 2017 | 208136000 | 53837297 |
| Monday, January 1, 2018 | 198405000 | 16080096 |
| Tuesday, January 1, 2019 | 224169000 | 18525736 |
| Wednesday, January 1, 2020 | 245044000 | 2024000 |
| Friday, January 1, 2021 | 252314000 | 2548000 |
| Saturday, January 1, 2022 | 268225000 | 61556000 |
| Sunday, January 1, 2023 | 304629000 | 188157000 |
| Monday, January 1, 2024 | 324203000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, cost efficiency remains a pivotal factor for success. This analysis delves into the cost of revenue trends for Telix Pharmaceuticals Limited and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, Taro consistently demonstrated a robust cost management strategy, with a notable 70% increase in cost efficiency by 2023. In contrast, Telix, while showing a significant leap in 2023 with a 700% increase from its 2014 figures, experienced more volatility. The data reveals that Taro's cost of revenue peaked in 2024, while Telix's data for 2024 remains unavailable, highlighting potential gaps in reporting. This comparative study underscores the importance of strategic financial planning in maintaining competitive advantage in the pharmaceutical sector.
AbbVie Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Novartis AG and Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Analyzing Cost of Revenue: Pharming Group N.V. and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Who Generates More Revenue? Telix Pharmaceuticals Limited or Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.